Economic Atlas
Companies/Ionis Pharmaceuticals, Inc.
Company profile

Ionis Pharmaceuticals, Inc.

NASDAQ: IONS · Healthcare · Biotechnology
PublicHQ Carlsbad, CA · San DiegoCIK 0000874015Reports USD
#160 of 1,418 Healthcare companies by revenue73rd-percentile growth
EA Score
71B
Revenue TTM
$1.1B
Rev growth YoY (TTM)
+47.5%
Net income (FY)
-$381.4M
Employees
1,402
as of 2026-08-05
Market cap
$9.2B
as of 2026-08-05

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$943.7M$943.7M2025
Net income-$381.4M-$381.4M2025
Operating income-$381.7M-$381.7M2025
Total assets$3.5B$3.5B2025
Liabilities$3.0B$3.0B2025
Equity$489.1M$489.1M2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Commercial Member52%
Royalty34%
Product14%
By geography

Not disclosed.

The read

What is Ionis Pharmaceuticals, Inc.’s revenue?

Ionis Pharmaceuticals, Inc. booked $943.7M in FY2025 revenue, growing 34% year over year — faster than most Healthcare companies we track, at a -40.4% net margin.

Peers · Healthcare
Claritev Corporation61CMadrigal Pharmaceuticals, Inc.64CThe Pennant Group, Inc.73BInspire Medical Systems, Inc.78B+Neogen Corporation65BANI Pharmaceuticals, Inc.82B+
Neighbors
San Diego →
QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B60CSempra$12.4B64CDexCom, Inc.$4.7B87AResMed Inc.$5.1B88AIllumina, Inc.$4.3B84B+
Key facts
CEOBrett Monia
SectorHealthcare
IndustryBiotechnology
HeadquartersCarlsbad, CA
ExchangeNASDAQ: IONS
Employees1,402
IPO date1991-05-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.